Overview, prevention and management of chemotherapy extravasation

doi:10.5306/wjco.v7.i1.87

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (19875)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

1964

WORD

532

HTML

14431

Tables (1-5)

291

Sum=17218

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1155

Download

1502

Sum=2657

Feb 10, 2016 (publication date) through Feb 1, 2025

Times Cited of This Article

Times Cited (131)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Feb 10, 2016; 7(1): 87-97
Published online Feb 10, 2016. doi: 10.5306/wjco.v7.i1.87

Table 1 The different types of the above mentioned drugs according to their vesicant potential

Neutrals	Inflammitants	Irritants	Exfoliants (may have low vesicant potential)	Vesicants
Asparaginase Bevacizumab bleomycin Bortezomib cetuximab, Cyclophosphamide	Bortezomib	Bendamustine	Aclacinomycin cisplatin Docetaxel liposomal Doxorubicin mitoxantrone Oxaliplatin paclitaxel	Actinomycin D
Cytarabine eribulin Fludarabine gemcitabine Ifosfamide	5-Fluorouracil methotrexate raltitrexed	Bleomycin		Dactinomycin daunorubicin Doxorubicin epirubicin Idarubicin mitomycin C Vinblastine vindesine
Melphalan rituximab		Carboplatin dexrasoxane		Vincristine vinorelbine
Trastuzumab		Etoposide
		Teniposide
		Topotecan

Citation: Kreidieh FY, Moukadem HA, El Saghir NS. Overview, prevention and management of chemotherapy extravasation. World J Clin Oncol 2016; 7(1): 87-97
URL: https://www.wjgnet.com/2218-4333/full/v7/i1/87.htm
DOI: https://dx.doi.org/10.5306/wjco.v7.i1.87